Whitehawk Therapeutics Inc. Common Stock (WHWK)

About WHWK

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

32

Website

ir.whitehawktx.com/

Fundamentals

1-day range

$4.6$5.03

Market cap

$212.98M

P/E (trailing)

—

P/E (forward)

-4.68

EPS (trailing)

$-3.59

Dividend yield

—

Beta

0.94

Avg. volume

461.3K

Forecasts

6 analyst ratings

Whitehawk Therapeutics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• WHWK

  Whitehawk Therapeutics Inc. Common Stock

  $4.65

  ▼ 4.52%
  Market cap $212.98MP/E —
  $1.76$5.5
• MSLE

  Satellos Bioscience Inc. Common Stock

  $8.92

  ▼ 7.23%
  Market cap $203.94MP/E —
  $7.08$18.98
• KROS

  Keros Therapeutics Inc. Common Stock

  $11.05

  ▼ 1.60%
  Market cap $200.10MP/E —
  $9.69$22.55
• GLSI

  Greenwich LifeSciences Inc. Common Stock

  $15.67

  ▼ 16.34%
  Market cap $198.74MP/E —
  $7.78$34.1
• SLGL

  Sol-Gel Technologies Ltd. Ordinary Shares

  $69.41

  ▼ 4.35%
  Market cap $230.38MP/E —
  $21$97.97
• IMUX

  Immunic Inc. Common Stock

  $15.4

  ▼ 5.52%
  Market cap $192.06MP/E —
  $5.06$17.43
• ADAG

  Adagene Inc. American Depositary Shares

  $3.68

  ▼ 5.64%
  Market cap $239.77MP/E —
  $1.3$4.85

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Whitehawk Therapeutics Q2 EPS $(0.20) Beats $(0.30) Estimate
  benzinga · 8/6/2026

Institutional Ownership

March 31, 2026

Total shares held

34.03M

Total value held

$118.39M

Institutional holders

59